GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial
Abstract Dichloroacetate (DCA) is an investigational drug targeting the glycolytic hallmark of cancer by inhibiting pyruvate dehydrogenase kinases (PDK). It is metabolized by GSTZ1, which has common polymorphisms altering enzyme or promoter activity. GSTZ1 is also irreversibly inactivated by DCA. In...
Saved in:
Main Authors: | Dan Dan Tian (Author), Samuel K. Bennett (Author), Lucy A. Coupland (Author), Kathryn Forwood (Author), Yadanar Lwin (Author), Niloofar Pooryousef (Author), Illa Tea (Author), Thy T. Truong (Author), Teresa Neeman (Author), Philip Crispin (Author), James D'Rozario (Author), Anneke C. Blackburn (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
by: Tomas Koltai, et al.
Published: (2024) -
The Effectiveness of Dichloroacetate on Human Glioblastoma Xenograft Growth Depends on Na+ and Mg2+ Cations
by: Donatas Stakišaitis, et al.
Published: (2021) -
Dichloroacetic acid-induced testicular toxicity in male rats and the protective effect of date fruit extract
by: Amira El Arem, et al.
Published: (2017) -
Sodium Dichloroacetate Pharmacological Effect as Related to Na-K-2Cl Cotransporter Inhibition in Rats
by: Jūratė Stanevičiūtė, et al.
Published: (2018) -
Design, Synthesis and Kinetic Study of Coumarin-Based Mutual Prodrug of 5-Fluorouracil and Dichloroacetic acid
by: bijps, et al.
Published: (2017)